These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 8565032

  • 21. The Phase III, double-blind, parallel-group controlled study of amlodipine 10 mg once daily in Japanese patients with essential hypertension who insufficiently responded to amlodipine 5 mg once daily.
    Fujiwara T, Ii Y, Hatsuzawa J, Murase H, Watanabe T, Murakami M, Kimura N, Buch J, Tsuchihashi T, Saruta T.
    J Hum Hypertens; 2009 Aug; 23(8):521-9. PubMed ID: 19148107
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Switching patients with uncontrolled hypertension on amlodipine 10 mg to single-pill combinations of telmisartan and amlodipine: results of the TEAMSTA-10 study.
    Neldam S, Edwards C, Jones R, TEAMSTA-10 Investigators.
    Curr Med Res Opin; 2011 Nov; 27(11):2145-53. PubMed ID: 21955225
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Efficacy and Safety of Nifedipine Coat-Core versus Amlodipine in Patients With Mild to Moderate Essential Hypertension: Comparison of 24-Hour Mean Ambulatory Diastolic Blood Pressure.
    Byyny RL, Shannon T, Schwartz LA, Rotolo C, Jungerwirth S.
    J Cardiovasc Pharmacol Ther; 1997 Apr; 2(2):77-84. PubMed ID: 10684445
    [Abstract] [Full Text] [Related]

  • 26. Comparison of the efficacy and safety of fixed-dose amlodipine/losartan and losartan in hypertensive patients inadequately controlled with losartan: a randomized, double-blind, multicenter study.
    Hong BK, Park CG, Kim KS, Yoon MH, Yoon HJ, Yoon JH, Yang JY, Choi YJ, Cho SY.
    Am J Cardiovasc Drugs; 2012 Jun 01; 12(3):189-95. PubMed ID: 22462558
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Comparative efficacy and safety of nisoldipine extended-release (ER) and amlodipine (CESNA-III study) in African American patients with hypertension.
    White WB, Saunders E, Noveck RJ, Ferdinand K.
    Am J Hypertens; 2003 Sep 01; 16(9 Pt 1):739-45. PubMed ID: 12944032
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Efficacy and safety of aranidipine enteric-coated tablets compared with amlodipine in Chinese patients with mild to moderate essential hypertension: a multicenter, randomized, double-blind, parallel-controlled clinical trial.
    Yan LR, Li YS, Chen GL, Wang L, Pang HM, Wu SY, Yu J, Li HM, Lin YZ, Zhao RP, Fan CM.
    J Cardiovasc Pharmacol; 2012 Jul 01; 60(1):8-14. PubMed ID: 22441301
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-to-moderate hypertension.
    Chrysant SG, Marbury TC, Robinson TD.
    J Hum Hypertens; 2003 Jun 01; 17(6):425-32. PubMed ID: 12764406
    [Abstract] [Full Text] [Related]

  • 36. I-COMBINE study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with amlodipine monotherapy in hypertensive patients uncontrolled with amlodipine 5 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study.
    Bobrie G, I-COMBINE Study Investigators.
    Clin Ther; 2012 Aug 01; 34(8):1705-19. PubMed ID: 22853848
    [Abstract] [Full Text] [Related]

  • 37. Efficacy, tolerability and influence on "quality of life" of nifedipine GITS versus amlodipine in elderly patients with mild-moderate hypertension.
    Pessina AC, Boari L, De Dominicis E, Giusti C, Marchesi M, Marelli G, Mattarei M, Mos L, Novo S, Pirrelli A, Santini M, Santonastaso M, Semeraro S, Uslenghi E, Kilama MO.
    Blood Press; 2001 Aug 01; 10(3):176-83. PubMed ID: 11688766
    [Abstract] [Full Text] [Related]

  • 38. Nifedipine gastrointestinal therapeutic system versus nifedipine coat-core: comparison of efficacy via 24-hour ambulatory blood pressure monitoring.
    Defina LF, Bookstaver DA, Goldfinger MP, Coffey TA.
    Ann Pharmacother; 1997 Aug 01; 31(7-8):819-22. PubMed ID: 9220037
    [Abstract] [Full Text] [Related]

  • 39. Comparison of the blood pressure-lowering effects and tolerability of Losartan- and Amlodipine-based regimens in patients with isolated systolic hypertension.
    Volpe M, Junren Z, Maxwell T, Rodriguez A, Gamboa R, Gomez-Fernandez P, Ortega-Gonzalez G, Matadamas N, Rodriguez F, Dass B, Kyle C, Clarysse L, Bryce A, Moreno-Heredia E, Germano G, Gilles L, Smith RD, Sanderson JE, CDSP-944 Study Group.
    Clin Ther; 2003 May 01; 25(5):1469-89. PubMed ID: 12867222
    [Abstract] [Full Text] [Related]

  • 40. Treatment of patients with essential hypertension: amlodipine 5 mg/benazepril 20 mg compared with amlodipine 5 mg, benazepril 20 mg, and placebo.
    Kuschnir E, Acuña E, Sevilla D, Vasquez J, Bendersky M, Resk J, Glazer R.
    Clin Ther; 1996 May 01; 18(6):1213-24. PubMed ID: 9001838
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.